Comments for MRX - Stockpickr! Your Source for Stock Ideas

Comments for MRX

Added By	Comments	Type	Date Added
High Dividends	5.3	Love	November 19, 2008
dougep	Valuation, possible acquisition candidate, major product in 2009	Love	October 06, 2008
chezmich@comcast.net	growth	Love	April 23, 2008
High Dividends	33%	Love	March 17, 2008
brothamarcou	Restylane does not seem to be as good a product as I had thought it would be	Hate	January 22, 2008
barrons2	Health-Care Sector Focus List - Price 25.92 on Jan. 2 by H&R Block Medicis is a leader in the U.S. dermatology market. [We believe that] having exceeded Street expectations for five of the last seven quarters, the company's consensus projected EPS estimate for 2008 of $1.54 (+26% versus '07) could prove conservative, should Reloxin [an anti-wrinkle treatment] be approved sooner than the anticipated 10-month regulatory review...The sales potential from Reloxin [is] significant [if] the product garner[s] just 20% of the market. And the shares' multiple of 23 times is at the low end of its historical range. Market-cap: $1.5 billion.	Love	January 05, 2008
High Dividends	10.4	Love	November 28, 2007
ICETEK	Increased demand in dermatological products. Growing industry.	Love	October 17, 2007
sarah z	Medicis announced a $200 million dollar buyback. In early August, the prescription acne and skin medication maker raised its full-year profit forecast. The stock trades for 14x cash flow.	Love	September 05, 2007
stallionsrunfree	kramer, cosmetic surgery, but I'm wearying of this already	Love	June 28, 2007
josephviju	Fundamentals	Love	June 28, 2007
ronagarm1	Everyone wants Restylane	Love	May 01, 2007
Greg NTG1 Parker	Miserable financials and negative cash flow. Makes me crave cheap scotch and the linoleum floor.	Hate	March 09, 2007
debbie reynolds	Cramer liked and it made sense	Love	January 14, 2007
Jerel Zoltick	Heath related stock in an area of high margin, cosmetic, dermatolgics	Love	January 03, 2007